252 related articles for article (PubMed ID: 29770620)
1. Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?
Wang CJ; Christie A; Folkert MR; Xie XJ; Albuquerque K
J Gynecol Oncol; 2018 Jul; 29(4):e49. PubMed ID: 29770620
[TBL] [Abstract][Full Text] [Related]
2. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors.
Tatebe K; Hasan Y; Son CH
Gynecol Oncol; 2019 Dec; 155(3):429-435. PubMed ID: 31610885
[TBL] [Abstract][Full Text] [Related]
4. Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis.
Wang W; Zou L; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Sun S; Jin M; Zhang F; Hou X; Wei L; Hu K
BMC Cancer; 2021 Jul; 21(1):774. PubMed ID: 34217240
[TBL] [Abstract][Full Text] [Related]
5. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
[TBL] [Abstract][Full Text] [Related]
6. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer.
Tétreault-Laflamme A; Nguyen-Huynh TV; Carrier JF; Samouëlian V; Sauthier P; Beauchemin MC; Barkati M
Int J Gynecol Cancer; 2016 Feb; 26(2):301-6. PubMed ID: 26745699
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
[TBL] [Abstract][Full Text] [Related]
9. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
[TBL] [Abstract][Full Text] [Related]
10. Vaginal brachytherapy for endometrial cancer.
Hass P; Seinsch S; Eggemann H; Ignatov T; Seitz S; Ignatov A
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1523-1530. PubMed ID: 29730776
[TBL] [Abstract][Full Text] [Related]
11. Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.
Lu SM; Chang-Halpenny C; Hwang-Graziano J
Gynecol Oncol; 2015 Apr; 137(1):28-33. PubMed ID: 25666606
[TBL] [Abstract][Full Text] [Related]
12. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
13. Overuse of external beam radiotherapy for stage I endometrial cancer.
Wright JD; Margolis B; Hou JY; Burke WM; Tergas AI; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2016 Jul; 215(1):75.e1-7. PubMed ID: 26875941
[TBL] [Abstract][Full Text] [Related]
14. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
[TBL] [Abstract][Full Text] [Related]
15. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
16. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
17. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
[TBL] [Abstract][Full Text] [Related]
18. Does the addition of radiation improve survival compared to chemotherapy alone in women with stage IV endometrial carcinoma? Analysis of the NCDB and SEER databases.
Barrington DA; Fox B; Meade C; Quick A; Felix AS; Chambers LM
Gynecol Oncol; 2022 Jun; 165(3):522-529. PubMed ID: 35469682
[TBL] [Abstract][Full Text] [Related]
19. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
[TBL] [Abstract][Full Text] [Related]
20. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
Horeweg N; Nout RA; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; Haverkort MAD; Mens JWM; Slot A; Wortman BG; de Boer SM; Stelloo E; Verhoeven-Adema KW; Putter H; Smit VTHBM; Bosse T; Creutzberg CL;
J Clin Oncol; 2023 Sep; 41(27):4369-4380. PubMed ID: 37487144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
